PortfoliosLab logoPortfoliosLab logo
AYTU vs. RCAT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AYTU vs. RCAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aytu BioPharma, Inc. (AYTU) and Red Cat Holdings, Inc. (RCAT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AYTU achieves a -11.92% return, which is significantly lower than RCAT's 57.12% return.


AYTU

1D
1.78%
1M
-8.40%
YTD
-11.92%
6M
2.23%
1Y
14.50%
3Y*
12.70%
5Y*
-53.73%
10Y*

RCAT

1D
-1.74%
1M
20.15%
YTD
57.12%
6M
50.67%
1Y
52.70%
3Y*
139.89%
5Y*
31.32%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AYTU vs. RCAT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AYTU
Aytu BioPharma, Inc.
-11.92%52.94%-40.14%-24.87%-86.00%-77.42%-38.35%22.41%-98.22%-44.94%
RCAT
Red Cat Holdings, Inc.
57.12%-38.29%1,360.23%-6.38%-54.81%-30.67%172.73%73,233.33%-94.74%-28.57%

Correlation

The correlation between AYTU and RCAT is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Sep 25, 2017

0.08

The correlation between AYTU and RCAT shifts across timeframes, from 0.08 (all time) to 0.26 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AYTU:

$24.07M

RCAT:

$1.51B

EPS

AYTU:

-$2.91

RCAT:

-$0.78

PS Ratio

AYTU:

0.47

RCAT:

25.90

PB Ratio

AYTU:

0.68

RCAT:

6.31

Total Revenue (TTM)

AYTU:

$56.60M

RCAT:

$52.98M

Gross Profit (TTM)

AYTU:

$36.14M

RCAT:

$2.86M

EBITDA (TTM)

AYTU:

-$27.34M

RCAT:

-$79.24M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AYTU vs. RCAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AYTU
AYTU Risk / Return Rank: 5151
Overall Rank
AYTU Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 4949
Sortino Ratio Rank
AYTU Omega Ratio Rank: 4949
Omega Ratio Rank
AYTU Calmar Ratio Rank: 5252
Calmar Ratio Rank
AYTU Martin Ratio Rank: 5353
Martin Ratio Rank

RCAT
RCAT Risk / Return Rank: 6262
Overall Rank
RCAT Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
RCAT Sortino Ratio Rank: 6767
Sortino Ratio Rank
RCAT Omega Ratio Rank: 6363
Omega Ratio Rank
RCAT Calmar Ratio Rank: 6161
Calmar Ratio Rank
RCAT Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AYTU vs. RCAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aytu BioPharma, Inc. (AYTU) and Red Cat Holdings, Inc. (RCAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AYTURCATDifference
Sharpe ratioReturn per unit of total volatility

-0.18

Sortino ratioReturn per unit of downside risk

-0.77

Omega ratioGain probability vs. loss probability

1.10

1.17

-0.08

Calmar ratioReturn relative to maximum drawdown

0.41

0.88

-0.47

Martin ratioReturn relative to average drawdown

0.97

1.77

-0.80

AYTU vs. RCAT - Sharpe Ratio Comparison

The current AYTU Sharpe Ratio is 0.27, which is lower than the RCAT Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of AYTU and RCAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AYTURCATDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.27

0.44

-0.18

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.63

0.27

-0.90

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.36

0.00

-0.36

Drawdowns

AYTU vs. RCAT - Drawdown Comparison

The maximum AYTU drawdown since its inception was -100.00%, roughly equal to the maximum RCAT drawdown of -99.21%. Use the drawdown chart below to compare losses from any high point for AYTU and RCAT.


Loading charts...

Drawdown Indicators


AYTURCATDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-99.21%

-0.79%

Max Drawdown (1Y)

Largest decline over 1 year

-35.47%

-60.08%

+24.61%

Max Drawdown (3Y)

Largest decline over 3 years

-70.24%

-67.16%

-3.08%

Max Drawdown (5Y)

Largest decline over 5 years

-99.12%

-92.25%

-6.87%

Current Drawdown

Current decline from peak

-100.00%

-28.23%

-71.77%

Average Drawdown

Average peak-to-trough decline

-95.15%

-66.07%

-29.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.92%

29.86%

-14.94%

Volatility

AYTU vs. RCAT - Volatility Comparison

The current volatility for Aytu BioPharma, Inc. (AYTU) is 14.09%, while Red Cat Holdings, Inc. (RCAT) has a volatility of 41.78%. This indicates that AYTU experiences smaller price fluctuations and is considered to be less risky than RCAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AYTURCATDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.09%

41.78%

-27.69%

Volatility (6M)

Calculated over the trailing 6-month period

33.39%

84.03%

-50.64%

Volatility (1Y)

Calculated over the trailing 1-year period

55.06%

119.85%

-64.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.66%

114.96%

-29.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

188.20%

29,243.53%

-29,055.33%

Dividends

AYTU vs. RCAT - Dividend Comparison

Neither AYTU nor RCAT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AYTU vs. RCAT - Financials Comparison

This section allows you to compare key financial metrics between Aytu BioPharma, Inc. and Red Cat Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00M20222023202420252026
12.41M
15.47M
(AYTU) Total Revenue
(RCAT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AYTU and RCAT have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RCAT has higher volatility (41.78%) compared to AYTU (14.09%). In terms of maximum drawdown, AYTU dropped -100.00% vs RCAT's -99.21%.

RCAT currently has the higher Sharpe Ratio (0.44 vs 0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AYTU and RCAT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer